Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127170951 | 12717095 | 1 | I | 20160830 | 20160906 | 20160906 | EXP | US-MYLANLABS-2016M1037477 | MYLAN | UPADHYAY A, BODAR V, MALEKZADEGAN M, SINGH S, FRUMKIN W, MANGLA A, ET AL. LOPERAMIDE INDUCED LIFE THREATENING VENTRICULAR ARRHYTHMIA. CASE-REP-CARDIOL 2016;:. | 0.00 | Y | 0.00000 | 20160904 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127170951 | 12717095 | 1 | PS | LOPERAMIDE | LOPERAMIDE | 1 | Oral | APPROXIMATELY 50 TABLETS A DAY OF 2 MG EACH, FOR MORE THAN 5 YEARS | Y | U | 72741 | ||||||||
127170951 | 12717095 | 2 | SS | LOPERAMIDE | LOPERAMIDE | 1 | Oral | APPROXIMATELY 100 TABLETS A DAY OF 2 MG EACH, 2 DAYS BEFORE ADMISSION | Y | U | 72741 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127170951 | 12717095 | 1 | Irritable bowel syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127170951 | 12717095 | LT |
127170951 | 12717095 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127170951 | 12717095 | Intentional product misuse | |
127170951 | 12717095 | Overdose | |
127170951 | 12717095 | Ventricular arrhythmia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |